Authors :
Lic. Marcelo Serrano Valeriano
Volume/Issue :
Volume 9 - 2024, Issue 11 - November
Google Scholar :
https://tinyurl.com/5e3drpyx
Scribd :
https://tinyurl.com/nhh2jvbk
DOI :
https://doi.org/10.5281/zenodo.14408663
Abstract :
Chagas disease causes the death of over
12,000 people annually worldwide. Discovered in 1909, it
had been infecting humans since 7000 BC. Chagas
disease progresses through different stages, with the
parasite residing intracellularly in the human body,
multiplying and causing cellular damage in cardiac
structures, leading to heart-related pathologies such as
arrhythmias or heart failure.
The objective of this research is to provide the
scientific community with a historical overview of the
various studies conducted on Chagas disease. Articles
were reviewed in databases like Pubmed and Scielo,
considering titles such as "chagas chronic
cardiomyopathy" and "autoimmunity in chagas
disease." Initially, a total of 2421 articles were gathered,
with 2008 excluded for being over five years old. An
additional 340 were discarded for not being classified as
review articles, and 50 more were rejected as their
abstracts did not contain relevant information.
Ultimately, 23 reference documents, published between
2019 and 2024, were included, meeting the inclusion
criteria set by the researcher.
The research began with the historical foundations
of the disease, exploring the scientific and biological
study of its discoverer. Subsequent stages detail the long-
term consequences of Chagas, such as chronic
cardiomyopathy, and the studies on the disease's
pathophysiology, understanding its impact on cardiac
structures. Advances in treatment approval were
described, highlighting their limited effectiveness in
managing cardiomyopathy. Various diagnostic methods
were also discussed, demonstrating how technology has
enabled the diagnosis and management of the disease's
progression in patients. This comprehensive review was
achieved through a historical-logical approach to the
literature.
Keywords :
Cardiomyopathy, Trypanosoma Cruzi, Inflammatory Autoimmunity, Cardiomyocyte Damage.
References :
- Alcides Bocchi E, Bulgarelli Bestetti R, Ibrahim Scanavacca M, Cunha Neto, Sarli Issa V. Chronic Chagas Heart Disease Management: From Etiology to Cardiomyopathy Treatment. ElSevier. 2017; 70(12, 19): p. 1510-1524.
- Rodrigues Coura J, Albajar Viñas P, Junqueira. Ecoepidemiology, short history and control of Chagas disease in. Scielo. 2014; 109(7): p. 856-860.
- Steverding D. The history of Chagas disease. Biomed Central. 2014; 7(317).
- Olivo Freites C, HenaoMartínez A. Chronic Chagas Disease—the Potential Role of Reinfections in Cardiomyopathy Pathogenesis. Springer Nature Link. 2022; 19: p. 279–289.
- Maldonado E, Rojas D, Urbina F, Solari A. The Oxidative Stress and Chronic Inflammatory Process in Chagas Disease: Role of Exosomes and Contributing Genetic Factors. Pubmed. 2021.
- Vigliano C, Chen C, Leone J. Chagas disease: Historic perspective. ElSevier. 2020; 1866(5).
- Goldaraz J, Casuriaga A, Pardo L, Giachetto G. Fiebre tifoidea: una etiología poco frecuente de síndrome febril prolongado en pediatría. Scielo. 2022; 9(2).
- Pino-Marín A, Medina-Rincón G, Gallo-Bernal, Duran-Crane A, Arango Duque Á, Rodríguez M, et al. Chagas Cardiomyopathy: From Romaña Sign to Heart Failure and Sudden Cardiac Death. 2021Pubmed; 505(5).
- Alcaide Alonso P. Dialnet. [Online].; 2003. Acceso 28 de Diciembre de 2024. Disponible en: https://dialnet.unirioja.es/servlet/tesis?codigo=27798.
- Medina-Rincón G, Gallo-Bernal S, Jiménez P, Cruz-Saavedra L, David Ramírez J, Juliana Rodríguez, et al. Molecular and Clinical Aspects of Chronic Manifestations in Chagas Disease: A State-of-the-Art Review. Pubmed. 2021; 1493(11).
- De Castro Neto A, da Silveira J, Arruda Mortara R. Comparative Analysis of Virulence Mechanisms of Trypanosomatids Pathogenic to Humans. Pubmed. 2021; 16(11).
- Ruiz Guzmán J. Historia de la enfermedad de chagas. Scielo. 2007; 30(2).
- V. Elizari M. La miocardiopatia chagasica. Perspectiva histórica. 1999; 59(2).
- Geovanny Pech-Aguilar A, Haro-Álvarez A, Rosado-Vallado M. Revisión actualizada sobre la fisiopatología de la cardiomiopatía chagásica. IMSS. 2020; 58(3).
- Paulo Silva Nunes J, Moraes de Paiva Roda V, Andrieux P, Cunha-Neto, Chevillard C.
- Inflammation and mitochondria in the pathogenesis of chronic Chagas disease cardiomyopathy. National Library of Medicina. 2024; 248(22).
- Revista Española de Geriatria y Gerontología. 2013; 48(5).
- Werner, Heitmann I, Leonor Jofré J, Sapunar J, Zulantay I, Torres. Guías clínicas de la enfermedad de Chagas 2006: Parte VI. Tratamiento antiparasitario de la enfermedad de Chagas. Revista Chilena de Infectología. 2008; 25(5).
- Respuesta inmune de las células del hospedero a la infección por Trypanosoma cruzi. Revista Médica del Hospital Nacional de Niños Dr. Carlos Sáenz Herrera. 2002; 37(1-2).
- Pardo Nancy, Condori Paxi M, Arnez Terrazas R. Miocardiopatía Chagásica con taquicardia ventricular: Hospital Obrero Nº 2 "Caja Nacional de Salud". Revista Científica Ciencia Médica. 2012; 15(1).
- Souza Santos E, Carvalho Silva, Bruna CdR, Cardim Barreto B. Immunomodulation for the Treatment of Chronic Chagas Disease Cardiomyopathy: A New Approach to an Old Enemy. Front Cell Infect Microbiol. 2021; 12(11).
- Giraldo Echavarría N, E. Echeverría L, Stewart, Gallego C, Saldarriaga C. Chagas Disease: Chronic Chagas Cardiomyopathy. Current Problems in Cardiology. 2021; 46(3).
- Llerena-Velastegui J, Lopez-Usina A, Mantilla-Cisneros C. Advances in the Understanding and Treatment of Chronic Chagas Cardiomyopathy. Cardiol Res. 2024; 16(4): p. 340–349.
- Molina I, Salvador, Sánchez-Montalvá A. Actualización en enfermedad de ChagasUpdate Chagas disease. Enfermedades Infecciosas y Microbiología Clínica. 2016; 34(2).
Chagas disease causes the death of over
12,000 people annually worldwide. Discovered in 1909, it
had been infecting humans since 7000 BC. Chagas
disease progresses through different stages, with the
parasite residing intracellularly in the human body,
multiplying and causing cellular damage in cardiac
structures, leading to heart-related pathologies such as
arrhythmias or heart failure.
The objective of this research is to provide the
scientific community with a historical overview of the
various studies conducted on Chagas disease. Articles
were reviewed in databases like Pubmed and Scielo,
considering titles such as "chagas chronic
cardiomyopathy" and "autoimmunity in chagas
disease." Initially, a total of 2421 articles were gathered,
with 2008 excluded for being over five years old. An
additional 340 were discarded for not being classified as
review articles, and 50 more were rejected as their
abstracts did not contain relevant information.
Ultimately, 23 reference documents, published between
2019 and 2024, were included, meeting the inclusion
criteria set by the researcher.
The research began with the historical foundations
of the disease, exploring the scientific and biological
study of its discoverer. Subsequent stages detail the long-
term consequences of Chagas, such as chronic
cardiomyopathy, and the studies on the disease's
pathophysiology, understanding its impact on cardiac
structures. Advances in treatment approval were
described, highlighting their limited effectiveness in
managing cardiomyopathy. Various diagnostic methods
were also discussed, demonstrating how technology has
enabled the diagnosis and management of the disease's
progression in patients. This comprehensive review was
achieved through a historical-logical approach to the
literature.
Keywords :
Cardiomyopathy, Trypanosoma Cruzi, Inflammatory Autoimmunity, Cardiomyocyte Damage.